The founders and leaders of tiny Bigfoot Biomedical each have at least one family member living with type 1 diabetes. So their motivation in creating the first artificial pancreas may have more of a personal motivation versus say, Medtronic, which recently confirmed it has applied for FDA approval for its version.
The Milpitas, CA, company, founded in 2014, has received FDA approval of an investigational device exemption (IDE) for the first clinical trial of its “smartloop” automated insulin delivery system.
